Search research articles
Contact Us
Filters
Showing results (181-190 of 274) with videos related to
Page
of 28
Sort By:
BMC Neurology
|
January 24, 2020
Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study
Augustine J Devasahayam, Arthur R Chaves, Wendy O Lasisi, et al.
Journal of Parkinson'S Disease
|
January 25, 2021
Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study
Thomas F Tropea, Noor Amari, Noah Han, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 25, 2017
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials
Alberto J Espay, Michael A Schwarzschild, Caroline M Tanner, et al.
The New England Journal of Medicine
|
March 29, 2013
Treatment of HCV infection by targeting microRNA
Harry L A Janssen, Hendrik W Reesink, Eric J Lawitz, et al.
Journal of Parkinson'S Disease
|
April 8, 2017
Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis
Laura Brennan, Kathryn M Devlin, Sharon X Xie, et al.
Neuro-Oncology
|
June 9, 2014
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report
Jack M Su, Patrick Thompson, Adekunle Adesina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept
John F de Groot, Yuji Piao, Hai Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies
Shivaani Kummar, Martin Gutierrez, Erin R Gardner, et al.
Oncotarget
|
April 19, 2017
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
Priscila H Goncalves, Lance K Heilbrun, Michael T Barrett, et al.
The Lancet. Oncology
|
March 9, 2017
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Lesley Seymour, Jan Bogaerts, Andrea Perrone, et al.
Page
of 28
Search research articles
Search
Showing results (181-190 of 274) with videos related to
Sort By:
Page
of 28
BMC Neurology
|
January 24, 2020
Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study
Augustine J Devasahayam, Arthur R Chaves, Wendy O Lasisi, et al.
Journal of Parkinson'S Disease
|
January 25, 2021
Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study
Thomas F Tropea, Noor Amari, Noah Han, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 25, 2017
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials
Alberto J Espay, Michael A Schwarzschild, Caroline M Tanner, et al.
The New England Journal of Medicine
|
March 29, 2013
Treatment of HCV infection by targeting microRNA
Harry L A Janssen, Hendrik W Reesink, Eric J Lawitz, et al.
Journal of Parkinson'S Disease
|
April 8, 2017
Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis
Laura Brennan, Kathryn M Devlin, Sharon X Xie, et al.
Neuro-Oncology
|
June 9, 2014
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report
Jack M Su, Patrick Thompson, Adekunle Adesina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept
John F de Groot, Yuji Piao, Hai Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies
Shivaani Kummar, Martin Gutierrez, Erin R Gardner, et al.
Oncotarget
|
April 19, 2017
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
Priscila H Goncalves, Lance K Heilbrun, Michael T Barrett, et al.
The Lancet. Oncology
|
March 9, 2017
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Lesley Seymour, Jan Bogaerts, Andrea Perrone, et al.
Page
of 28